Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probenecid-boosted flucloxacillin for outpatient skin infection
ACTRN12614000996662Phase 3Not yet recruiting
- Sponsor
- Nelson Bays Primary Health
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of flucloxacillin and probenecid in Not applicable, cellulitis, abscess and 1 more (2 arms), sponsored by Nelson Bays Primary Health. Primary endpoint: Clinical response of skin infection. Planned start Nov 2014; status: not yet recruiting.
02
Drugs
flucloxacillinprobenecid
03
Conditions
Not applicablecellulitisabscessWound infection (WI)
Beyond the preview
Go deeper on ACTRN12614000996662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000996662.